GSK233705

CAS No. 850607-58-8

GSK233705( —— )

Catalog No. M34566 CAS No. 850607-58-8

GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 182 In Stock
10MG 274 In Stock
25MG 448 In Stock
50MG 641 In Stock
100MG 914 In Stock
200MG Get Quote In Stock
500MG 1832 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK233705
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    850607-58-8
  • Formula Weight
    425.4
  • Molecular Formula
    C24H29BrN2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C[C@@H]1C[C@]2([N+](C)(C)[C@@](C1)(CC2)[H])[H])(C#N)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Otenzepad

    Otenzepad is a selective antagonist of M2 mAChR with IC50s of 386 nM and 640 nM for rat heart and rabbit peripheral lung.

  • M4 mAChR agonist-1?

    M4 mAChR agonist-1 is an effective agonist of M4 mAChR (EC50 >10 μM).

  • Atropine methyl brom...

    Atropine methyl bromide, a muscarinic receptor (mAChR) antagonist.